Zepatier is a combined antiviral agent. Combines two direct-acting antivirals with different mechanisms and non-overlapping resistance profiles to target hepatitis C virus (HCV) at different stages of the viral life cycle.
The drug is intended for the treatment of chronic hepatitis C genotypes 1, 3 or 4 in adult patients.
Active ingredient: grazoprevir 100 mg and elbasvir 50 mg
Prescription medicine
Delivered from Germany